Dow Down 1.29% Nasdaq Down 3.25%

More On IMU.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

Ownership

  • Major Holders
  • Insider Transactions
  • Insider Roster

Financials

Imugene Ltd. (IMU.AX)

-ASX
0.01 0.00(0.00%) Feb 4, 9:46PM EST
Prev Close:0.01
Open:0.01
Bid:0.01
Ask:0.01
1y Target Est:N/A
Beta:N/A
Next Earnings Date:N/A
Day's Range:0.01 - 0.01
52wk Range:0.01 - 0.02
Volume:6,173,032
Avg Vol (3m):3,167,630
Market Cap:19.05M
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in AUD.

Headlines

  • No Headlines available for IMU.AX at this time.

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):22.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-16) :0.00
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Imugene Limited, an immuno-oncology biopharmaceutical company, together with its subsidiaries, engages in the research and development of HER2 +ve gastric and breast cancer immunotherapies in Australia. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback